ATE283288T1 - Mutantes hämoglobin mit niedriger affinität für sauerstoff - Google Patents

Mutantes hämoglobin mit niedriger affinität für sauerstoff

Info

Publication number
ATE283288T1
ATE283288T1 AT96915428T AT96915428T ATE283288T1 AT E283288 T1 ATE283288 T1 AT E283288T1 AT 96915428 T AT96915428 T AT 96915428T AT 96915428 T AT96915428 T AT 96915428T AT E283288 T1 ATE283288 T1 AT E283288T1
Authority
AT
Austria
Prior art keywords
oxygen
mutant hemoglobin
hemoglobin
low affinity
mutant
Prior art date
Application number
AT96915428T
Other languages
English (en)
Inventor
Chien Ho
Hyun-Won Kim
Tong-Jian Shen
Original Assignee
Univ Carnegie Mellon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Carnegie Mellon filed Critical Univ Carnegie Mellon
Application granted granted Critical
Publication of ATE283288T1 publication Critical patent/ATE283288T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AT96915428T 1995-05-01 1996-04-30 Mutantes hämoglobin mit niedriger affinität für sauerstoff ATE283288T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/432,071 US5843888A (en) 1995-05-01 1995-05-01 Low oxygen affinity mutant hemoglobin
PCT/US1996/006075 WO1996034974A1 (en) 1995-05-01 1996-04-30 Low oxygen affinity mutant hemoglobin

Publications (1)

Publication Number Publication Date
ATE283288T1 true ATE283288T1 (de) 2004-12-15

Family

ID=23714638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96915428T ATE283288T1 (de) 1995-05-01 1996-04-30 Mutantes hämoglobin mit niedriger affinität für sauerstoff

Country Status (8)

Country Link
US (1) US5843888A (de)
EP (1) EP0826064B1 (de)
JP (1) JP3170289B2 (de)
CN (1) CN1159450C (de)
AT (1) ATE283288T1 (de)
AU (1) AU5720596A (de)
DE (1) DE69633918D1 (de)
WO (1) WO1996034974A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2299049C (en) * 1997-05-02 2008-07-15 Baxter Biotech Technology S.A.R.L. Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
US6486123B1 (en) 2000-06-21 2002-11-26 Carnegie Mellon University Low oxygen affinity mutant hemoglobins
WO2004083383A2 (en) * 2003-03-14 2004-09-30 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Globin variant gene methods and compositions
US8551536B2 (en) 2007-08-31 2013-10-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes
JP2016027326A (ja) * 2014-06-26 2016-02-18 アークレイ株式会社 測定方法、測定装置および溶離液
CA3070172A1 (en) 2017-07-18 2019-01-24 VirTech Bio, Inc. Blood substitutes comprising hemoglobin and methods of making
WO2019203302A1 (ja) * 2018-04-18 2019-10-24 積水メディカル株式会社 ヘモグロビン分析方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4865974A (en) * 1985-09-20 1989-09-12 Cetus Corporation Bacterial methionine N-terminal peptidase
US5013662A (en) * 1985-09-20 1991-05-07 Cetus Corporation Bacterial methionine n-terminal peptidase
US4870017A (en) * 1985-09-20 1989-09-26 Cetus Corporation Bacterial methionine N-terminal peptidase
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
US5173426A (en) * 1989-10-06 1992-12-22 Yale University DNAs encoding genetically engineered low oxygen affinity mutants of human hemoglobin
US5239061A (en) * 1990-06-20 1993-08-24 Research Corporation Technologies, Inc. Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin

Also Published As

Publication number Publication date
JP3170289B2 (ja) 2001-05-28
CN1159450C (zh) 2004-07-28
WO1996034974A1 (en) 1996-11-07
AU5720596A (en) 1996-11-21
CN1183120A (zh) 1998-05-27
EP0826064B1 (de) 2004-11-24
DE69633918D1 (de) 2004-12-30
EP0826064A1 (de) 1998-03-04
US5843888A (en) 1998-12-01
EP0826064A4 (de) 1998-11-18
JPH11506314A (ja) 1999-06-08

Similar Documents

Publication Publication Date Title
GB2234749B (en) Low affinity mutant hemoglobins and wholly artificial hemoglobins as blood substitutes
MY102806A (en) Human interleukin-3 and muteins thereof
ATE117805T1 (de) Stabile hämoglobinreferenzlösung.
EA200000449A1 (ru) Модифицированные витамины к-зависимые полипептиды
AU1750297A (en) Humanized green fluorescent protein genes and methods
DK0643767T3 (da) Osteogene peptider
KR900700600A (ko) DNA를 코오딩하는 IgE수용체 α-서브유니트 또는 그의 단편
DE69132902D1 (de) Methoden zur identifizierung heterofunktionaler fusionsproteine
KR890007750A (ko) 인간 조직 인자 억제제의 dna 클론
EP0754229A1 (de) Afamin: ein menschliches serum albumin ähnliches protein
DE69233348D1 (de) Verwendung von allosterischen hämoglobinmodifikatoren zur verringerung der sauerstoffaffinität im blut
DE69633918D1 (de) Mutantes hämoglobin mit niedriger affinität für sauerstoff
AU2308992A (en) Cysteine depleted il-6 muteins
EP0336779A3 (de) Durch kovalenten Ersatz von Wasserstoffbrücken stabilisierte Polypeptide
DK63588A (da) Termostabile gummi/metal-bindemidler
IL113252A0 (en) Eph receptors binding ligands
KR910003095A (ko) 사람의 단백질 c변이체 및 이의 제조방법
AU3082795A (en) Hard and soft wheat thioredoxins h, homologous proteins, dna fragments coding for said proteins and methods for preparing same
ATE160172T1 (de) Cdna, die für peptidyl-glycin alphaamidierende monooxygenase (pam) codiert
AU558572B2 (en) Retro-inverso analogue of the (5-14) decapeptide of equine angiotensinogen
KR890008166A (ko) 융합 단백질의 선택적 분해 방법
Belfaiza et al. E. coli aspartokinase II-homoserine dehydrogenase II polypeptide chain has a triglobular structure
DE69610410D1 (de) Verwendung eines Osmolyten zur Verringerung oder Aufhebung von nichtkovalenten Bindungen biologischer Moleküle an inerten Oberflächen
SU722976A1 (ru) Среда дл закалки
WO1994021273A3 (de) VERWENDUNG VON ANGIOGENIN UND/ODER α1-MICROGLOBULIN UND/ODER KOMPLEMENTFAKTOR D ZUR BEGRENZUNG DER SEKRETION VON PROTEINEN

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties